Previously reported Phase 1/2 data on WU-CART-007 demonstrated clinically manageable safety and evidence of anti-leukemic activity with an overall response rate of 91% and composite complete remission ...

Phase 1 MAD dosing completed for SION-451 and final MAD cohort of SION-719 planned; Interim data in healthy volunteers show potential to provide ...

AptarGroup, Inc., a global leader in drug and consumer product dosing, dispensing and protection technologies, today ...

Previous research has suggested an increased risk for neuropsychiatric symptoms in people living with HIV who are being treated with INST (Integrase Strand Transfer) inhibitor antiretrovirals, Gillian ...

Rodabe N. Amaria, MD, explains a trial of OBX-115, a novel engineered tumor infiltrating lymphocyte therapy, in checkpoint ...

In April 2024, Barinthus Bio announced topline results from the Phase 1b/2 APOLLO dose-ranging trial (also known as HPV001) ...

In this randomized study, microdosing LSD was not more effective than placebo in reducing ADHD symptoms in adults.

In myeloma treatment, acute CRS is a common but treatable AE associated with CAR T-cell therapy and bispecific antibodies, ...

The first randomised controlled trial of microdosing LSD as a treatment for ADHD found the psychedelic drug wasn’t any more ...

When your dog has a cough, it can be unpleasant. Here are some vet recommended treatment options for cough suppressants for ...

Eager to be a part of water's story? These roles are just a small sample of careers in the water utility sector, and there ...

With millions in the bank as a motive, Lana Clayton sat back and watched as husband Steven suffered a slow and painful death ...